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Absrracr A micro double diffusion test (MD), allowing the identification of precipita- 
tion band 5 by identity reaction, using a rabbit specific anti-component 5 serum. was 
evaluated for the immunological diagnosis of Chagas'disease. The previousstudies on 
the Trypanosoma cruzi specificity of component 5 [g] were completed, shoning it to 
be absent in Leishmania brazilienis, but present in different strains of 7: cruzi. 200 sera 
from Bolivian patients were studied. (88 with a positive xenodiagnosis, 45 with 
mucocutaneous leishmaniasis but without Chagas' disease, and 67 controls). Band 5 
was found in 74 (84.1%) of the sera with positive xenodiagnosis but was never found 
either in the leishmaniasis or  in the control groups. MD, allowing an easy detection of 
T. cruzi specific band 5, cheap and simple to perform, can be recommended in 
association with other serological tests, when highly specific immunodiagnosis of 
Chagas' disease is required 
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Introduction 
The importance of the immunodiagnosis of chronic Chagas' disease has already been 
widely emphasized. However, many human sera with positive serological reactions for 
Trypanosoma cruzi also have positive reactions with antigens of other flagellates such 
as T. rangeli, Leishmania donovani or L. brudiensis [I-81. The existence of shared 
epitopes between flagellate antigens [9-113 can explain such obsenations. Conse- 
quently various methods have been proposed to increase the specificity of the immuno- 
diagnosis of Chagas' disease, using: I .  other parasite forms. like amastigotes or 
trypomastigotes, assumed to be more specific for T. cruzi than epimastigote forms [5. 
12, 131; 2. other antigenic extraction procedures [7]: 3. absorption of the positive 
human sera with the cross-reacting antigens, before determination of the anti- T. cru:; 
antibody level [3]; 4. specific purified antigen of T. cruzi [11. 151. 
Such a T. cruzi antigen, the so-called component 5. has been demonstrated without 
shared epitopes with L.. donovani, L. mesicana. T. bnicei or T. rangeli [9, 161. 
Moreover, using ~mmunoelectrophoresis (IEP). anti-component 5 precipitaticg anti- 
bodies could lie demonstrated in 72.6% ofsera from patients chronically infected by T. 
cruzi[l7]. The aims of this work was to complete the specificity study of component 5 
and to evaluate a micro double diffusion test (MD), allowing the identification of 
precipitation band 5 by identity reaction using a specific rabbit anti-component 5 
serum, for specific immunodiagnosis of Chagas' disease. hiD. previously used for 
.4 
specific diagnosis of other parasitic disease [I&], was expected to be simple to perform, 
avoiding preparation of a large quantity of purified component 5, and higher sensitive 
than IEP. 
Materials and Methods 
Human wra. 
Sera were obtained from 200 UuÌ;tian patients, divided into three groups according to their geographical 
origin. The f i r b t  group ( I )  contained X X  patients (mean age 39 f I3 years) with positive xenodiagnosis.They 
came from sourhern loulands, areas known to be highlyendemic for Chagas'disease. but where Icishmania- 
sis had never been found. They were asymptomatic or with cardiac or digestive symptoms compatible with 
the chronic phase of Chagas'disease. The second group (2) contained 45 patients(mean age 29 A 9  years) 
with-dimcal evidence of mucocutaneous leishmaniasis (35 with typical primary cutaneous ulcerations with 
surrounding indurations and IO with typical mutilations of the face). They lived in northern lowlands('Beni' 
and 'Alto Beni'). areas known to be endemic for leishmaniasis but free of Chagas'disease. The third group 
(3)  was a control group of 67 asymptomatic patients (mean age 25 f 5 years). from highland areas 
('Altiplano') cxcmpt of both infections and who had never travelled in the endemic areas. 
T. cru:; and L.. braziliensis antigens. 
T. cruzi epimastigotes (Tehuantepec strain) were cultivated in cell free GLSH monophasic medium at 2X°C 
[19]. After 7 culture days. the parasites were harvested by centrifugation at 800 g for 15 min at 4°C and 
washed three times with Hank's balanced salt solution. Six grams (wet weight) of epimastigotes were 
suspended in 36 ml of 1% NaCl, frozen and desintegrated five times in a hydraulic press (LKB X press) at 
18000 psi and then centrifuged a t  26.000g for Ih a t  4DC. The supernatant was dialyzed against distilIed water 
for 24h at  4'C. lyophilized and used as a soluble extract of 'I: rruzi. Soluble antigenic extracts of other six 
different isoenzymic strains of T. cruzi, classified as I. I b, IC. 2.2a and 2b according to Tibayrenc er al. [20] 
were prepared as the T. rruzi Tehuantepec strain for the complementary study of specificity. L. brariliensis 
promastigoles (LV65 strain) were obtained from cell-free culture on SNN medium. modified according to 
Deker-Jackson & Honizberg [21]. A. L 6ra:iliensis soluble extract was prepared as for T. rruzi. 
T. cru:; coniponenr 5.20 mg of rru:i(Tehuantepecstrain) solubleantigenic extract were resuspended in4 
ml o f  distilled water and added with an equal volume of chloroform; methanol solution (2) I). The mixture 
was shaken for 30 min at  room temperature and centrifuged at  1.000gfor30 min at4cC.Theaqueous phase 
was collected and extracted twice in the same way. Organic solvents were evaporated and glycoproteins were 
precipitated by the addition of 3 volumes of ethanol for 4 hours at  -.20iC. After centrifugation (1.000 g-30 
min). the precipitate was washed with ethanol. dried. and resuspended in 2 ml of distilled water. Thesolution 
was centrifuged. dialyzed against distilled Hater for 24 hours at  4.C and Ipphilized to obtain 2.5 mg of a 
componcnt 5-rich fraction. 
Rahhir ininlune sera. 
One rabbit \!as immunired with the total solubleextract of 'I: eruzi. for thespecificitystudyofcomponent 5.  
Another rabbit was injected with fraction 5 and used in the diagnosis evaluation of MD. The immunization 
procedure used simultaneous multiple intradermic injections. according to Vaitukaitis er al. [22] with 2 mg 
of antigen. The rabbits were boosted by weekly subscapular injections of 1 mg of antigen over six weeks. 
The presence of precipitating anti-component 5 antibodies in the rabhit sera was controlled in IEP and in 
immunodiffusion by identity reaction with a reference monospecific anti-component 5 serum, prepared 
according to Afchain er al. [9]. 
Micro dvuble dgfusion rest (MO). 
M D  was performed on microscope slides( 25 X80mm)covcrcdwith4mlof I%agarose(IBF-France)inO.l 
M veronal buffer, pH 8.2. Three patterns of wells for sera and antigenic extract were punched for oneslide, 
allowing simultaneous study of 12 different human sera (figure I). 60 pl of human sera. concentrated to  I2 rl 
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by Iyophilizatiotr. was placed in peripheral wells whereas 12 p1 of I / 4  diluted rabbit anti-5 immune serum 
was put in the central wells. The two micro-wells were filled with 2 p (24 pg) of T. rmzi antigcnic cxtract. 
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'Then. the slides were incubared in  a moist chamber, at room temperature for 24h. They were washed by 
immersion in 0.1 veronal buffer pH 8.2 for 48h. demineralized in distilled water for Ih  at room 
temperature, dried and stained by Coomassie blue. The  test was positive when one of the precipitation bands 
produced by the human sera showed an  identity reaction with the band5 obtained withtheanti-component 
5 immune scrum. 
Results 
Complemenrarx studi? on the T. cruzispecificitv of component 5. As shown infigure2, 
precipitation band 5 was demonstrated to be present and identical in the 6 studied 
different isoenzymic strains of T. cruzi, but it was not found in the L. braziliensis 
an tige n ic extract. 
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Figure 1. M D  pattern (RIS = anti-component 5 rabbit h t " e  serum; HS = h u m a n  serum; T =soluble 
antigenic extract of T. cruri). 
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Figure 2. Immunodiffusion test studying the specificity ofcomponcnt 5 (1. IB. 2, 2A, ZB=solubIeantigenic 
extract of different isoenzymic strains of T. cruricontainhg component 5 (AS); Tc =component 5 fraction 
(T. cm5 Tehuantcpcc strain; LB = soluble antigenic extract of L bruziliensisP= anti  T. cnc i r abb ì t  scrum). 
Figure 3. M D with human s s a  !. L. 3, 9. 10. 1 I :  human sera showing precipitation band 5 (A5):4,5,6,7,8, 
12 = band 5 negative sera: T = 7: c n c i  antigenic extract.n=anti-Component 5 rabbit immune serum), 
Ei*aluaiion of the micro double dgus ion  lesi I O  i d e n t o  lkeprecipirarion band5.74 
Out of 88 (84,1%) sera from the group I presented a well-defined precipitation band, 
identical to.the band obtained with the specific anti-component 5 sera in MD, as 
shown inJigrire 3. S o  sera of leishmaniasis group 2 and of control group 3 presented a 
precipitation band. 
Discussion 
The T. cruzispecificity ofcomponent 5 in relation to  T. brucei, T. rangeli, L. donovani, 
and L. mexicana was previously demonstrated by Afchain el al. C9, 163. The present 
results completed this specificity study, showing its presence in different T. cruzi 
strains but the absence of component 5 in L. braziliensis. Moreover band 5 was not 
found in sera from patients with mucocutaneous leishmaniasis or Bolivian controls. 
Consequently it can be affirmed that the presence of anti-component 5 antibodies in a 
serum ensures the diagnosis of Chagas' disease. 
The  M D  sensitivity of band 5 detection was 84.1%, which is higher than the 72.6% 
previously obtained using IEP [17]. Indeed MD avoids the electrophoresis step, 
necessary t o  identify component 5 in IEP, increasing the antigen concentration 
available for the diffusion step. Moreover, ip MD. the identification of band 5 in 
human serum is easy using the identity reaction with a rabbit specific anti-component 5 
immune serum. 
M D  requires little human o r  rabbit serum or T. c r u 5  antigenic extract and allows 
simultaneous study of many sera using microscope slides. The specific anti-compocent 
5 serum is easy to  produce. 40 ml of a high quality serum, from one immunized rabbit, 
allow 40.000 patient sera to  be tested. Moreover human sera with a predominant 
precipitation band 5 could be progressively selected by IEP or immunodiffusion to be 
used instead of rabbit serum. 
Since other serological tests. such as immunofluorescence. complement fixation test 
o r  ELISA, also with Bolivian sera, though less specific, obtained a better relative 
sensitivity (99-1005) [17], the routine use of M D  for the immunodiagnosis of Chagas' 
disease, instead of more sensitive tests, is unsuitable. However, when the classical 
serological tests are positive for different flagellate antigens. this can be due to shared 
epitopes between flagellates or mised infections with various flagellates. Indeed, most 
South american areas are known to be endemic for both leishmaniasis and Chagas' 
disease and it is essential t o  obtain a confirmation of the diagnosis of Chagas'disease, 
since clinical and therapeutic management of leishmaniasis and Chagas' disease are 
very different. I n  such cases, in association with other serological tests, MD, with 
identity reaction, cheap and simple to  perform (not requiring enzyme o r  fluorochro- 
me-labelled reagents). can be recommended as a highly specific tool for immunodiag- 
nosis of Chagas' disease. 
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